Press Room

Press Releases and Statements

Your search for Press Release returned 1000 results.

MAY 06, 2015

The Bill & Melinda Gates Foundation to Fund Disease Surveillance Network in Africa and Asia to Prevent Childhood Mortality and Help Prepare for the Next Epidemic

SEATTLE (May 6, 2015) – At its Global Partners Forum, the Bill & Melinda Gates Foundation will announce the Child Health and Mortality Prevention Surveillance Network (CHAMPS), a network of disease surveillance sites in developing countries. These sites will help gather better data, faster, about how, where and why children are getting sick and dying. This data will help the global health community get the right interventions to the right children in the right place to save lives. The network will also be invaluable in providing capacity and training in the event of an epidemic, such as Ebola or SARS. The Gates Foundation plans an initial commitment of up to $75 million on the effort.



APRIL 06, 2015

Emilio Emini Director of HIV

SEATTLE (April 6, 2015) — The Bill & Melinda Gates Foundation today announced that Emilio Emini, Ph.D, has been named director of HIV for the Global Health program. He will assume his new position on July 6, 2015.


MARCH 18, 2015

New Chief Digital Officer Joins Bill & Melinda Gates Foundation

SEATTLE, WA, USA (March 19, 2015) – The Bill & Melinda Gates Foundation today announced that Todd Pierce will join the organization in the newly created role of Chief Digital Officer. He comes to the foundation from salesforce.com where he served as Senior Vice President of the Healthcare and Life Sciences industry. Prior to salesforce.com, Pierce was Chief Information Officer at Genentech and for the County of Santa Clara, California, and held technology leadership roles at Roche and Veteran’s Affairs. Additionally, he has held key positions on multiple non-profit and foundation boards.


MARCH 05, 2015

The Bill & Melinda Gates Foundation and CureVac Collaborate to Accelerate the Development of Transformative Vaccine Technology

SEATTLE, WA, USA and TÜBINGEN, GERMANY (March 5, 2015) – The Bill & Melinda Gates Foundation and CureVac today announced that the foundation has made a commitment to invest $52 million (€46 million) in CureVac, a leading clinical-stage biopharmaceutical company specializing in mRNA-based vaccine technologies. As part of the agreement, the foundation will also provide separate funding for several projects to develop prophylactic vaccines based on CureVac’s proprietary messenger RNA (mRNA) platform. In addition, CureVac’s longstanding investor dievini Hopp BioTech announced a commitment of $24 million (€21 million) of additional equity.





Visit Our Blog